The Pharmaceutical Journal
Vol 276 No 7384 p91
21 January 2006

Statutory Committee inquiries

The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.30am on Monday 23 January, Tuesday 24 January, Wednesday 25 January and Thursday 26 January 2006 to hear the following inquiries:

Monday 23 January
1. A resumed inquiry into a complaint by the Council of the Society against Lubna Khan (registration number 1057173), which alleges that the theft or alternative misappropriation of £800 from her employer may amount to misconduct.

2. An inquiry into a complaint by the Council of the Society against Mustafa Bhaiji (registration number 1050805), which alleges that the supply of methadone contrary to Regulation 16(4) of the Misuse of Drugs Regulations 2001 and the failure to make an entry in the Controlled Drugs Register in respect of the supply of methadone (in breach of Regulations 19(1) and 20(b) of the Misuse of Drugs Regulations 2001, may amount to misconduct.

Tuesday 24 January
3. An inquiry into a complaint by the Council of the Society against Andrew Mortara (registration number F357), which alleges that a number of dispensing errors, the making of disparaging comments in front of customers and the making of a personal telephone call in the pharmacy while customers were waiting may amount to misconduct.

Wednesday 25 January
4. An inquiry into a complaint by the Council of the Society against Ramesh Mavji Patel (registration number 90343) and Judds (Chemists) Ltd (identification number 1000754), which alleges that the adoption of a system by Mr Patel which resulted in the submission of erroneously endorsed prescriptions to the Prescription Pricing Authority and Mr Patel's presentation of a cheque for £25 to a patient may amount to misconduct.

Thursday 26 January
5. A resumed inquiry into a complaint by the Council of the Society against Manherlal Keshavlal Shah (registration number 63471) and MAM International Ltd (identification number 1001688), which alleges that the supply of out-of-date medicines; the supply of enalapril tablets on which there was no expiry date or batch number; a failure to implement adequate systems for the removal of out-of-date medicines; the presence in the dispensary of medicines where the date of expiry and batch number were not present and/or had been removed; the presence in the dispensary of medicines labelled years previously from other pharmacies for various patients which were stored among the other, alphabetically arranged, current stock, indicating that they might be reused; and the presence of a number of European products which did not bear a product licence number, may amount to misconduct.

David Gomez
Secretary to the Statutory Committee